Scarica l'app Stockscreener
37.83
0.25%
-0.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$38.07
Aprire:
$38.94
Volume 24 ore:
1.63M
Relative Volume:
0.83
Capitalizzazione di mercato:
$5.77B
Reddito:
$3.24B
Utile/perdita netta:
$304.90M
Rapporto P/E:
18.19
EPS:
2.08
Flusso di cassa netto:
$156.70M
1 W Prestazione:
+4.16%
1M Prestazione:
-16.65%
6M Prestazione:
-41.16%
1 anno Prestazione:
-57.94%
Intervallo 1D:
$37.34
$39.00
Intervallo di 1 settimana:
$35.00
$41.34
Portata 52W:
$34.10
$90.03
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Confronta BRKR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
37.98 | 5.77B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
127.38 | 215.93B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
93.41 | 138.09B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.38 | 132.98B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.59 | 104.78B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.00 | 39.98B | 5.72B | 4.17B | 259.90M | 6.97 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
Why Is Life Science Focused Bruker Stock Trading Higher On Friday? - Benzinga
Bruker Crushes Q1 Revenue Estimates: Double-Digit Growth Signals Strong Performance - Stock Titan
Bruker's Game-Changing Acquisition Revolutionizes Hospital Infection Detection Technology - Stock Titan
Bruker Launches FoodScreener Module for Comprehensive NMR-based Profiling of Honey - Global Food Industry News
Is Now An Opportune Moment To Examine Bruker Corporation (NASDAQ:BRKR)? - Yahoo Finance
Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up - Yahoo Finance
Bruker unveils world’s first 1.3 GHz NMR spectrometer - Investing.com
Groundbreaking 1.3 GHz NMR Tech Revolutionizes Molecular Research - Stock Titan
Revolutionary Multi-Nuclear NMR Technology Transforms Pharma and Battery Research - Stock Titan
Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain? - MSN
Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029 - GlobeNewswire Inc.
Bruker installs novel MRI polarizer at UCSF for cancer research - Investing.com
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR - Quantisnow
Game-Changing MRI Breakthrough: New Technology Delivers 10,000x Better Imaging for Cancer Research - Stock Titan
Bruker stock hits 52-week low at $42.68 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $42.68 amid market challenges - Investing.com
Is Bruker Corporation (BRKR) an Oversold Value Stock to Buy According to Hedge Funds? - Insider Monkey
Bruker : Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes - MarketScreener
Bruker stock hits 52-week low at $44 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $44 amid market challenges - Investing.com
Bruker Corporation (BRKR): Among Michael Burry’s Top Holdings - Insider Monkey
Based On Its ROE, Is Bruker Corporation (NASDAQ:BRKR) A High Quality Stock? - Yahoo Finance
Michael Burry’s Top Holdings Were Gaining While NVDA Was Crashing - Insider Monkey
Bruker Co. (NASDAQ:BRKR) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
FY2027 Earnings Estimate for Bruker Issued By Zacks Research - Defense World
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail - Yahoo Finance
Bruker Co. (NASDAQ:BRKR) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Bruker at Leerink Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa
Bruker at Leerink Conference: Navigating Challenges and Opportunities - Investing.com
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $45.13 amid market challenges - Investing.com Australia
Bruker Corp’s chief accounting officer buys $23,697 in stock - Investing.com India
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds - Investing.com
US Bancorp DE Has $694,000 Stock Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Proficio Capital Partners LLC Invests $608,000 in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker motion backfires in US patent dispute with 10x Genomics, Harvard - MLex
Zacks Research Predicts Bruker’s Q4 Earnings (NASDAQ:BRKR) - Defense World
Bruker Corp. to Host Earnings Call - ACCESS Newswire
Bruker at TD Cowen Conference: Strategic Growth in Healthcare - Investing.com
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM - Yahoo Finance
Bank of New York Mellon Corp Grows Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Is Bruker Corporation (BRKR) the Best Medical Technology Stock to Buy According to Analysts? - Yahoo Finance
BRUKER CORP SEC 10-K Report - TradingView
Truist Financial Corp Invests $910,000 in Bruker Co. (NASDAQ:BRKR) - Defense World
Sanctuary Advisors LLC Increases Stake in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker launches advanced 3D X-ray microscope - Investing.com
Could This New X-Ray Technology Transform Scientific Research? Bruker's X4 POSEIDON Promises 10X Better Resolution - StockTitan
Bruker stock hits 52-week low at $48.04 amid market challenges - Investing.com
Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications – Company AnnouncementFT.com - Financial Times
Bruker Corporation (BRKR) is on Detractors’ list of The London Company SMID Cap Strategy - Yahoo Finance
What Makes Bruker Corporation (BRKR) a Lucrative Investment? - Yahoo
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bruker Corp Azioni (BRKR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
1.50%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):